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Abstract: The most common medical cause of excessive daytime sleepiness (EDS) is obstructive 
sleep apnea (OSA). Specifically, among an estimated 14 million US commercial drivers, 17–28% or 
2.4 to 3.9 million are expected to have OSA. Based on existing epidemiologic evidence, most of these 
drivers are undiagnosed and not adequately treated. Untreated OSA increases the risk of vehicular 
crashes as documented in multiple independent studies and by meta-analysis. Therefore, identifying 
commercial drivers with OSA and having them effectively treated should decrease crash-related fa-
talities and injuries. Several strategies are available for screening and identifying drivers with OSA. 
The simplest and most effective objective strategies use body mass index (BMI) cutoffs for obesity. 
Functional screens are promising adjuncts to other objective tests. The most effective approach will 
likely be a combination of a good questionnaire; BMI measures; and a careful physician-obtained 
history complemented by a functional screen.
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Introduction
Obstructive Sleep Apnea, or OSA, is a critical occu-
pational health concern in the transportation industry. It 
affects a substantial percentage of today’s transportation 
operators, particularly in the trucking sector. OSA is a 
syndrome characterized by sleep-disordered breathing due 
to recurrent upper airway obstruction, which in turn results 
in arousals from sleep and impaired sleep quantity and 
quality. Accordingly, OSA produces diurnal and nocturnal 
symptoms. These include excessive daytime sleepiness 
(EDS), sleep attacks, psychomotor deficits, and disrupted 
nighttime sleep due to frequent arousals.
Probably the most important consequence of OSA in the 
context of occupational health is EDS. OSA is the most 
common medical cause of EDS, which is a significant 
public safety concern for any safety-sensitive occupa-
tion, especially commercial driving
1). Indeed, somewhere 
between 10 and 30 percent of all vehicle crashes are 
estimated to have sleepy drivers as a root cause
2–4). Not 
surprisingly, drivers with OSA have an increased crash 
risk estimated across various studies to be in the range of 
2–11 fold
5).
Moreover, OSA is common among commercial drivers. 
Howard et al. analyzed a population of Australian truck 
drivers, found 60% to have disordered breathing during 
sleep, and diagnosed 16% with OSA
6). The number one 
risk factor for OSA is obesity, and 45 to 50 percent of 
truck drivers in the United States are obese
7–9). As a result, 
about 15 to 30 percent of North American commercial 
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drivers are estimated to have OSA. It is widely under-
diagnosed in at-risk populations and under-treated among 
those who have been diagnosed
6, 10–12). All of these facts, 
taken together, demand an active public health response 
from occupational medicine physicians, transportation 
industry leaders, and government regulatory agencies to 
effectively screen drivers for OSA and to ensure treatment 
compliance among those diagnosed with OSA
13, 14).
Risk Factors
The major risk factors for OSA in transportation work-
ers and in the general population include obesity, age, 
and male gender. Alterations in craniofacial structure are 
also associated with OSA, and may account in part for 
observed ethnic variations in OSA prevalence along with 
ethnic differences in sensitivity to the metabolic conse-
quences of increasing adiposity.
Obesity
Obesity is the most important risk factor for OSA, both 
in the general population and among commercial driv-
ers
13–16). A study of Japanese commercial vehicle operators 
found that a weight gain of 10 kg or more or an increase in 
body mass index (BMI) of 5 kg/m
2 or more were associ-
ated with increased sleepiness and sleep disordered breath-
ing
17). North American research has identified a strong 
relationship between the risk of OSA and a BMI greater 
than 26 kg/m
2 
18). In non-Asian populations, the relative 
risk of OSA is greater than 10-fold in persons with a BMI 
>29 kg/m
2 
19, 20). A study in Israel found that over 75% 
of commercial drivers with a BMI greater than 32 kg/m
2 
had OSA, and most of these drivers demonstrated objec-
tive evidence of EDS, although none of them voluntarily 
reported any symptoms
21). Given the strong relationship 
between obesity and OSA, and the reluctance of most 
professional drivers to report sleepiness, BMI criteria are 
important screening metrics in conjunction with other 
tools to identify drivers with OSA.
Age
Age is a risk factor, but also a likely disease modifier 
for OSA. Bixler et al. conducted a large-scale study of 
men in the United States to assess the relationship between 
age and OSA
22). After controlling for BMI, they found that 
OSA prevalence increases with age, while on the other 
hand OSA severity decreases with age. Spanish research-
ers, also found a direct relationship between increasing 
age and the prevalence of OSA
23).
Male sex
In addition to obesity and age, male gender has been 
linked with an increased likelihood of OSA
24–26). In par-
ticular, pre-menopausal women appear to be hormonally 
protected from OSA
27). The predominantly male industry 
of transportation operators, particularly sedentary truck 
drivers, together with the aging population and increas-
ing US obesity epidemic have created a perfect storm of 
high OSA prevalence among commercial drivers in North 
America
28).
Ethnicity and OSA risk
The majority of studies on OSA have been conducted 
with participants in the United States, Europe and Aus-
tralia who have been primarily Caucasian or of European 
descent. Thus, less data is available on other ethnic popu-
lations. Villaneuva et al reviewed the existing literature, 
finding that Asian populations have a higher risk of OSA 
at lower levels of obesity than Caucasian populations. The 
review also suggests that African-American ethnicity may 
be an OSA risk factor
29). In a study comparing Hispanic, 
White, and Japanese test subjects, OSA prevalence overall 
was positively correlated with increasing BMI in each 
group, although the distribution of BMI is different in each 
group
30).
A unique concern for the Asian population is the occur-
rence of OSA, metabolic syndrome and other consequenc-
es of increasing adiposity at lower BMI ranges than among 
European populations
31). Thus, the main difference in risk 
factors between the United States and Japan is that most 
drivers with OSA in Japan are not obese by international 
criteria (BMI >/=30 kg/m
2)
17, 30, 32). Some have suggested 
that this may be due to differences in facial structure, as 
well as differences in the distribution and the amount of 
body fat per body weight
27, 31). Therefore, despite a lower 
prevalence of obesity in Japan as compared to the United 
States, up to 25% of the commercial driver population in 
both countries have been found to have sleep-disordered 
breathing
32).
Consequences of OSA for Transportation 
Workers
Transportation workers with OSA may suffer from 
Excessive Daytime Sleepiness (EDS) as well as impaired 
vigilance, which in turn puts them at an increased risk for 
motor vehicle crashes.SLEEP APNEA IN COMMERCIAL DRIVERS 15
Excessive daytime sleepiness (EDS) and increased crash 
risk
OSA is the most frequently diagnosed cause of Exces-
sive Daytime Sleepiness, or EDS
21, 33, 34). EDS can impair 
a person’s judgment and abilities, resulting in serious 
consequences for drivers, given that prolonged wakeful-
ness has been shown to produce impairment similar to that 
of alcohol consumption
35). Indeed, sleepiness has been 
shown to contribute directly to highway crashes
36). Given 
this information, EDS is an especially dangerous condition 
for commercial vehicle operators who drive professionally. 
Indeed, the proportion of commercial vehicle crashes due 
to the driver’s sleepiness has been estimated at up to 30% 
of these accidents
2–4).
OSA and increased crash risk
Accordingly, OSA has also been repeatedly associated 
with an increased crash risk among non-professional 
drivers; however, there are limitations to the studies
37–42). 
These studies may be biased due to underreporting in the 
occupational setting, where a crash may have negative job 
consequences for the driver. Conversely, over-reporting is 
possible from selection bias when cases are drawn from 
sleep clinics where patients may have been referred due 
to sleep-related motor vehicle crashes
43). Several other 
studies, however, eliminated reporting biases through the 
use of government or insurance company-based records 
of crashes, rather than self-reports. These investigations 
also support an increased risk of crashes associated with 
OSA
38, 42–47). Moreover, a recent review and meta-analysis 
by Tregear and colleagues examined seven different lit-
erature databases and identified 18 unique studies of crash 
risk, two involving commercial drivers and the remainder 
examining persons with non-commercial licenses
45). 
Their meta-analysis based on the 10 studies that provided 
adequate information to calculate a crash relative risk and 
95% CI found that drivers with OSA had more than a two-
fold increase in the risk of motor vehicle crashes (crash 
Relative Risk = 2.43, 95% CI: 1.21–4.89) when compared 
to drivers without OSA.
Recently published data support this assertion as well. 
Because of the close relationship of OSA and obesity in 
drivers, Anderson et al prospectively looked at obesity 
among newly recruited commercial drivers and subse-
quent crash risk
48). They used two different multivariate 
statistical models, which both demonstrated an over 50% 
increase in subsequent crash risk for drivers reporting a 
BMI of >/=35 kg/m
2 at the time of trucking firm hire.
Experimental data also support that untreated OSA is 
detrimental to driving, and additionally that persons with 
OSA are more sensitive to sleep deprivation and alcohol 
consumption
49). Australian researchers conducted simu-
lated driving assessments and found that OSA patients 
had more steering deviation (less ability to maintain their 
lane of traffic) than the control subjects. OSA patients also 
demonstrated increased steering deviation even when the 
control subjects had a restricted time in bed or were given 
alcohol and the OSA patients were allowed to sleep as 
normal. When OSA patients were sleep restricted or given 
alcohol, they suffered additional marked increases in steer-
ing deviation on the driving simulator
49).
Given the strong associations between OSA and both 
driving impairment and motor vehicle accidents; it is clear 
that OSA in professional drivers should be identified and 
treated aggressively, as well as subject to adequate regula-
tion.
Management of OSA Risk in the Transporta-
tion Industry
Programs to identify and treat commercial drivers 
with OSA through screening, diagnosis and compliance 
monitoring programs are promising risk management/
mitigation strategies for the transportation industry. Ide-
ally, these medical programs should also be accompanied 
by administrative controls related to hours of service, shift 
work and other factors to minimize driver fatigue.
Screening for OSA
In this review, “screening” refers to the use of question-
naires, anthropometric measures, and other subjective and 
objective criteria applied to all drivers to determine which 
drivers should then undergo a “diagnostic” procedure for 
confirming or excluding the presence of OSA. “Diagnosis” 
and “diagnostic” procedures for OSA refer to sleep stud-
ies that measure or estimate the presence of sleep apnea 
(see below). In North America, OSA screening modalities 
include subjective/self-reported items regarding sleep 
disorders, daytime sleepiness and sleep-related symptoms; 
objective measures such as BMI and neck circumference 
cutoffs and blood pressure guidelines; guidelines that com-
bine subjective and objective criteria; as well as functional 
performance screens designed to detect impairment related 
to fatigue or sleepiness. Table 1 summarizes a number of 
these screening methods in terms of several characteristics 
of performance and effectiveness in detecting OSA.S KALES et al. 16
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Subjective screening modalities
Unfortunately, most self-reports of information related 
to OSA by commercial drivers have a low yield. Diverse 
data show that commercial drivers generally do not report 
their symptoms and diagnoses accurately because of 
the economic and occupational implications of an OSA 
diagnosis
10, 12–14, 21, 28). These concerns range from the in-
convenience of an having to go through a diagnostic work-
up after positive screening; being pulled out of service 
during an medical evaluation; and potentially losing one’s 
job and/or medical certification for professional driving. 
Given this reluctance to self-report symptoms of OSA, it 
is especially important that occupational physicians take 
the time to also employ objective measures (see below) as 
well as ask supplementary questions of higher risk drivers.
United states commercial driver’s medical examination 
form
In the United States, commercial vehicle drivers are 
required to complete a federal medical form that currently 
includes only one question regarding sleep disorders. It 
asks the yes or no question, “Do you have sleep disorders, 
pauses in breathing while asleep, daytime sleepiness, 
loud snoring?” Among the drivers who are at high risk 
for OSA, 85% self-reported the answer to this question as 
“No.”
12) Obviously, this status quo approach is inadequate 
and ineffective by itself.
Epworth sleepiness scale (ESS)
The Epworth sleepiness scale, or ESS, is a questionnaire 
designed to identify persons with EDS either due to life-
style circumstances (e.g. chronic sleep deprivation based 
on work or social schedules) or a sleep disorder (e.g. OSA, 
idiopathic hypersomnia and narcolepsy)
50). The ESS ques-
tionnaire asks an individual to rate his/her average likeli-
hood of falling asleep (self-rated from 0 [no chance of 
dozing] to 3 [high chance of dozing]) during eight differ-
ent common situations (e.g. watching television or sitting 
and talking to someone). A score greater than 10 indicates 
probable EDS. Most occupational guidelines encourage 
physicians to recommend further testing for OSA when 
the ESS exceeds 10
13, 14). An accurate ESS assessment 
can provide valuable screening information, and high ESS 
scores have been associated with an increased accident 
risk in a study of North Carolina drivers
51). Unfortunately, 
among commercial drivers, the ESS has been found to 
have a low yield and to produce results, which are often 
likely to be inaccurate. Most OSA-affected commercial 
drivers report very low ESS scores at driver certification 
exams (range 2–4)
10, 12), which are lower than ESS scores 
from the general community
50). For example, Parks et al. 
found a mean ESS score of 3.4 among commercial driv-
ers who ultimately were diagnosed with OSA as part of a 
multi-modal OSA screening program during commercial 
driver medical certifications
12). Another OSA screening 
study during commercial driver medical examinations 
by Talmage et al. found an inverse relationship between 
Table 1.   Comparison of various OSA screening strategies in a typical population of commercial drivers in North America
Screening 
Criterion
Estimated Performance during an Occupational Examination*
Mean AHI of 
Cases Detected
Study, Year Prevalence of 
Positive Screens
OSA Case 
Yield1 Sensitivity2 Positive Predic-
tive Value3
US Federal CDL Exam 
Driver Sleep Question
0–3% 0–2% 0–7% – – Talmage et al., 200810) 
Parks et al., 200912)
ESS>10 3.4% 1.4% 4% – 37+/−28 Berger et al., 201253)
SomniSage 
Questionnaire
30% 21% 75% 68% 40+/−28 Berger et al., 201253)
BMI>/=30 kg/m2 50% 19% 68–70% 38% 41+/−29 Berger et al., 201253) 
Gurubhagavatula et al., 20048)
Joint Task Force 12–13% 10–12% 36–46% 79 − >/=95% 42–49 Talmage et al., 200810) 
Parks et al., 200912) 
Xie et al., 20117)
BMI>/=40 kg/m2 6–7% 6–7% 23% >95% 51+/−32 Berger et al., 201253)
*Based on available data and below assumptions. 1Percent of Commercial Drivers who will screen positive and then be diagnosed with OSA (defined 
as AHI>10) via Polysomnography (PSG). 2Assumes that 28% of North American Drivers have Sleep Disordered Breathing (AHI>5) based on the study 
by Gurubhagavatula et al. (2004)8). 3Calculated as: (Number of Drivers with a Positive Screen and Positive OSA on PSG ÷ Number of Drivers with a 
Positive Screen) × 100%.SLEEP APNEA IN COMMERCIAL DRIVERS 17
reported ESS scores and OSA diagnosis, which they at-
tributed to “potential denial or deception” on the part of 
the drivers
10). In contrast, an anonymous, population-
based survey of transportation operators conducted by the 
National Science Foundation found a mean ESS score of 
5.2 for all professional truck drivers assessed- a population 
that included drivers with and without OSA
52). Moreover, 
in another anonymous survey of US truck drivers, over 
20% reported falling asleep at traffic lights
9), casting fur-
ther doubt on the validity of ESS reported at certification 
exams.
Somni-Sage
® questionnaire
Precision Pulmonary Diagnostics, LLC (PPD), has 
developed a self-report, online screening questionnaire for 
OSA
53). PPD conducted an unpublished pilot study of 100 
commercial drivers, which analyzed the drivers’ complete 
medical records and their polysomnogram (PSG) results. 
The survey instrument, known as Somni-Sage
®, was then 
constructed based on the pilot study results and a medi-
cal literature review. The goal was to provide trucking 
companies with a simple, cost-effective tool for identify-
ing drivers with an increased likelihood of having OSA. 
Drivers suggested as high-risk based on the questionnaire 
are then ideally referred for PSG for diagnostic confirma-
tion. This OSA screening instrument is trademarked as 
Somni-Sage
®, and it has been awarded a US Patent (US 
7,720,696B1)
53).
In addition to questions about subjective symptoms, 
Somni-Sage
® also has incorporated items designed to 
obtain reliable surrogate measures of objective data (self-
reports of height and weight and medical conditions)
53). 
Thus, Somni-Sage
® incorporates weighted values for 
BMI, neck circumference, hypertension and other medical 
co-morbidities, as well as heavy snoring, witnessed ap-
neas, other symptoms and, as well as EDS. EDS is elicited 
in two ways. The first is the ESS questionnaire described 
above, which is embedded within Somni-Sage
®. The sec-
ond is the simple question: “Do you become drowsy while 
driving?” Additionally, some of the symptoms elicited by 
Somni-Sage
® assess OSA risk in ways that are unfamiliar 
to drivers as being related to OSA (e.g. nocturia).
Berger et al retrospectively assessed the Somni-Sage
® 
Questionnaire effectiveness using data from three large 
US trucking firms who used the instrument in employer-
mandated OSA screening programs of their commercial 
drivers
53). The investigators were able to assess both the 
diagnostic yield of sending drivers determined as high-risk 
for a PSG and the positive predictive value of a high-risk 
designation on Somni-Sage
®. In this population of over 
19,000 drivers who completed the questionnaire, almost 
6,000 drivers (30%) were found to be at higher risk for 
OSA
53). The employer-based programs utilized overnight, 
in-lab, PSG for diagnostic confirmation. Despite the limi-
tation that all higher-risk drivers were not sent for testing 
by their employers, among over 2,000 higher-risk drivers 
who underwent PSG, 68% were diagnosed with definite 
OSA (an apnea–hypopnea index (AHI) greater than 10) 
and 80% had at least probable OSA (an AHI of 5 or more). 
A conservative prevalence estimate for definite OSA (AHI 
>10) was 21% among the commercial driver population 
studied
53).
Another interesting finding regarding Somni-Sage
® 
is that the patented statistical algorithm used to identify 
higher risk drivers appears to be robust and effective 
despite drivers’ efforts to change their behavior to avoid 
a sleep apnea diagnosis. In 2006, the first year that the 
Schneider National trucking firm began using this ques-
tionnaire, almost 30% of drivers admitted that they had 
EDS. However, the Berger et al study documented that 
the proportion of drivers willing to admit EDS went down 
every year afterwards reaching a nadir of 6% in 2010
53). 
The commercial driver population’s characteristics were 
the same during this study period, therefore, the likely 
reason behind this drop was that drivers talked to each 
other, learned that the company was trying to identify 
sleepy drivers, and changed their answers to avoid being 
diagnosed with a sleep disorder. Nevertheless, the Somni-
Sage questionnaire and program maintained a positive 
predictive value of roughly 70% throughout the period 
2006–2010. Given that the estimated prevalence (case 
yield) of OSA remained at about 20%, the questionnaire’s 
performance did not seem to suffer even after drivers 
changed their behavior.
Diagnostic interviews by the commercial driver medical 
examiner
Although evidence-based data are lacking to directly 
support a more probing interview of higher risk commer-
cial drivers by the commercial driver medical examiner, 
common sense and the clinical experience of the senior 
author (SNK) and his colleagues is that such an approach 
can have a fairly high supplemental yield to other mea-
sures. Drivers who deny symptoms and diagnoses on 
questionnaires and self-report forms will often divulge 
much more information when skilled physicians take the 
time to ask repetitive and additional questions in creative 
ways. For example, many obese male drivers check off a S KALES et al. 18
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no answer to “snoring,” yet when they are asked in joking 
way whether their bed partners complain about their snor-
ing, their answers may change
54). Recently, a professional 
male driver at high risk for OSA (obesity, hypertension, 
increased neck circumference and atrial fibrillation) was 
seen and reported an ESS of only 4, but on direct ques-
tioning, he admitted dozing off at stops while waiting for 
his passengers. Likewise, when they are asked about past 
diagnostic procedures or told that they are at high risk for 
OSA, drivers may volunteer that they have undergone a 
PSG in the past or even that they have a continuous posi-
tive airway pressure (CPAP) machine at home
12).
Objective screening modalities
Objective screening tools have the advantage that they 
are directly measured and are not subject or at least less 
subject to manipulation, deception and under-reporting 
by drivers. These metrics may relate directly to OSA risk: 
BMI, neck circumference and blood pressure guidelines. 
Also included in this section are consensus occupational 
health guidelines that combine both subjective and objec-
tive criteria, but rely more heavily on the latter objective 
measures.
Body mass index (BMI)
As discussed earlier in the review, the presence of 
obesity in any given driver or patient markedly increases 
that individual’s likelihood of having OSA, even without 
considering any other factors. This is especially true of 
middle-aged men who comprise the majority of American 
commercial drivers. This makes BMI a very important and 
valuable first line tool for OSA risk assessment. A number 
of occupational health studies of commercial driver popu-
lations directly support BMI as an effective OSA screen-
ing tool.
In Israel, Dagan et al. recommend the use of Body Mass 
Index, or BMI, to identify and diagnose EDS in com-
mercial motor vehicle operators
21). Drivers with a BMI of 
32 or greater were referred to the Institute for Fatigue and 
Sleep Medicine for PSG and multiple sleep latency tests 
(MSLT) to rule out sleep apnea and EDS, respectively. 
This testing was done at the behest of the Traffic Safety 
Department of the Israeli Ministry of Health as part of the 
drivers’ license renewal process. A respiratory disturbance 
index (RDI) of >/=5 was used to classify drivers as having 
sleep-disordered breathing (SDB). In sleep laboratory test-
ing, 78% of the drivers in Dagan’s series had SDB accord-
ing the study criteria. Supporting the lack of effectiveness 
of subjective reports in occupational driver testing, 100% 
of the drivers in this study denied symptoms of OSA 
and EDS. Yet, on MSLT almost half of these drivers had 
abnormal results consistent with objectively measured 
EDS
21).
At the University of Pennsylvania, Gurubhagavatula et 
al conducted a study of Pennsylvania commercial driver’s 
license holders who were recruited using population-based 
methods
55). Drivers voluntarily consented to the research 
study, which was done outside of any occupational medi-
cal certification. This study used a two-step risk stratifica-
tion procedure, beginning with a basic questionnaire for 
all commercial drivers, followed by oximetry conducted 
with a subset of drivers
55). Groups of both high and lower 
risk drivers were tested using PSG, which allowed the 
investigators to estimate the overall population prevalence 
of varying levels of SDB/OSA, as well as screening 
criteria performance characteristics. The best BMI cutoff 
for identifying any level of OSA (AHI>/=5) was 30 kg/
m
2, which had an estimated sensitivity of 70%. For severe 
OSA (AHI>30), a BMI of 33 kg/m
2, performed best with 
a 77% sensitivity and 70% specificity
8). Based on these 
findings, the United States Medical Expert Panel recom-
mended a BMI screening cutoff of 33 kg/m
2 in 2008
56).
Joint task force guidelines
In 2006, the Joint Task Force (JTF) of three important 
groups representing a variety of expertise: the American 
College of Chest Physicians, the American College of Oc-
cupational and Environmental Medicine, and the National 
Sleep Foundation published consensus guidelines in the 
Journal of Occupational and Environmental Medicine and 
Chest for identifying and diagnosing OSA in commercial 
vehicle operators (Table 2)
13, 14), Subsequent to the pub-
lication of the JTF recommendations, two independent 
studies published in 2008 and 2009 provided support for 
the validity and high positive predictive value of the JTF 
guidelines. Talmage et al reported a series of 1,443 con-
secutive drivers screened using the JTF criteria, resulting 
in 190 (13%) drivers being recommended for PSG
10). Of 
the drivers who underwent PSG, 95% were diagnosed with 
OSA, supporting an estimated positive predictive value 
of 95%. In another independent study of 456 commercial 
drivers screened with the same criteria, Parks et al referred 
53 drivers (12%) for PSG. All 20 drivers who underwent 
subsequent PSG or provided information about prior PSG 
were found to have OSA
12). In the absence of US Federal 
regulations specifying other required methods to screen for 
OSA, the JTF guidelines have become a de facto commu-
nity standard in the US occupational medicine community.SLEEP APNEA IN COMMERCIAL DRIVERS 19
Functional performance screens
Functional performance screens are modalities that can 
identify otherwise unrecognized, impaired vigilance pos-
sibly related to fatigue or sleepiness. These tests can po-
tentially identify the sleepiest drivers who should receive 
prioritized, more urgent sleep laboratory testing in an 
expeditious manner; as well as drivers who are function-
ally impaired, but fall outside the sensitivity ranges of the 
screening criteria described above
57).
Psychomotor vigilance test
The Psychomotor Vigilance Test (PVT) has been used in 
multiple studies to detect decrements in performance due 
to sleep deprivation
58, 59). The PVT measures a person’s 
reaction time to a visual cue that occurs rapidly and at ran-
dom intervals of two to ten seconds
60). When administered 
to a group of emergency responders that may be called on 
to drive professionally and commercial truck/bus drivers 
at medical certification examinations, the PVT was found 
to be a practical and promising in-clinic or point of care 
objective method for identifying safety-sensitive workers 
with impaired vigilance
57). The abnormal vigilance pat-
terns (response times of more than five seconds or two or 
more “super lapses” of equal to or greater than one sec-
ond) detected by the PVT were found almost exclusively 
in a subset of obese males whose anthropometrics put 
them at high risk for OSA. Notably, some of these subjects 
would have escaped detection by the JTF screening crite-
ria as described above.
Driving simulators
Driving simulators are another type of functional testing 
that may become another potential adjunct to OSA screen-
ing. As their name implies, driving simulators simulate the 
environment and performance of driving in a laboratory or 
clinic environment devoid of actual safety risks. Simula-
tors vary in their sophistication from simple video-game 
type tasks to so-called high-fidelity driving simulators that 
attempt to mimic driving an actual vehicle
13, 14). The pri-
mary measure on most of these tests is steering deviation 
or tracking– how closely a driver follows their designated 
lane of travel as opposed to deviating right and left in the 
lane
49, 61, 62). Secondary measures often include a reaction 
time component, often associated with simulated braking 
times, as well as crashes. Crashes tend to indicate even 
more serious sleepiness
49).
For the most part, various driving simulators consis-
tently demonstrate decrements in performance among 
subjects with OSA and other sleep disorders, as well as 
subjects who have been sleep deprived. However, there is 
not yet robust evidence associating simulator performance 
with on-road driving performance
13, 14). Moreover, the 
National Highway Traffic Safety Administration (NHTSA) 
determined as part of a literature review that “the results 
reveal that measures commonly used to measure disease 
severity in sleep apnea are not very useful in discriminat-
ing between individuals who are likely to perform poorly 
on laboratory based measures putatively related to driving 
performance or who are at risk for crashes”
63).
A simulator that has attracted attention recently, the 
Aus-Ed Driving Simulator, was developed by collaborat-
Table 2.   Summary of the joint task force consensus recommendations for screening commercial drivers for OSA
Criteria for (+) OSA Screen
Drivers meeting one or more of the six criteria are considered to have OSA or probable OSA
Subjective Criteria (1–4)
-Historical Findings (1–3) 1. Any of the following symptoms: snoring, excessive daytime sleepiness, witnessed apneas
2. History of MVC likely related to sleep disturbance (run off road, at-fault, rear-end collision)
3. Previous OSA diagnosis; prior PSG with AHI>5; reported CPAP prescription and/or use
-Epworth Sleepiness Scale 4. ESS score>10
Objective Criteria (5, 6) 5. Sleeping in examination or waiting room
6. Two or more of the following*
a. BMI >/= 35 kg/m2
b. NC>17 inches in men, 16 inches in women
c. Hypertension (new, uncontrolled, or requiring >/= 2 medications for control)
* Most Drivers are identified through Criterion 6. Adapted from J Occup Environ Med. 2006; 48 (9 Suppl): S4–S3713) and Chest 2006; 
130: 902–90514). Abbreviations: OSA, obstructive sleep apnea; MVC, motor vehicle collision; PSG, polysomnography; AHI, apnea-
hypopnea index; CPAP, continuous positive airway pressure; ESS, Epworth sleepiness scale; BMI, body mass index; kg/m2, kilograms 
per meter squared; NC, neck circumference.S KALES et al. 20
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ing teams of researchers based in Australia and Edinburgh, 
Scotland deriving its name from those two locations. A 
major study using the Aus-Ed on a group of drivers with 
OSA and a control group that did not have OSA is sum-
marized above in the section: OSA and Increased Crash 
Risk
49).
Further research is necessary to determine whether 
simulators can distinguish drivers at high-risk for OSA and 
occupational sleepiness from their colleagues and whether 
they can predict on-road crash risk.
Diagnosis of OSA
“Diagnosis” and “diagnostic” procedures for OSA refer 
to sleep studies that confirm or exclude the presence of 
sleep disordered breathing by measuring or estimating 
the RDI or AHI. In most cases, diagnostic procedures are 
reserved for subjects who report OSA symptoms, demon-
strate impairment consistent with possible OSA or who 
have screened as higher risk for OSA as described above.
Polysomnography (PSG)
Polysomnography, or PSG, remains the gold standard 
for diagnosing and assessing OSA, and when conducted in 
the laboratory, it produces the most reliable results
64). “Type 
I” PSGs are overnight, technician-attended, in-laboratory 
sleep studies with physiologic monitoring via 14–16 chan-
nels and serve as the reference standard among PSGs. A 
“type II” PSG records the same information as a type I 
PSG, but lacks technician attendance and may be done in 
the laboratory or outside of a lab setting
28).
Although it is the current gold standard, errors can still 
occur and these include data loss, artifacts, and intra- and 
inter-rater variability in scoring events. Additionally, dif-
ferent sleep laboratories use different types of monitoring 
equipment, which may change the sensitivity of event 
recognition. Nonetheless, most sleep laboratories use very 
similar montages for baseline PSG. These include electro-
encephalogram (EEG) leads; electrooculographic (EOG) 
leads; electromyography (EMG) leads; a modified elec-
trocardiogram lead; an airflow signal (a nasal thermistor 
and/or a nasal cannula pressure transducer); a measure of 
respiratory effort of the chest and abdomen (either respira-
tory inductance plethysmography or impedance pneumog-
raphy); and a pulse oximeter to monitor oxygen saturation. 
All other diagnostic tools are, therefore, compared to PSG 
for quality standards
28).
Portable monitors (PMs)
Although PSG is the gold standard for OSA diagnosis, 
given the large number of professional drivers at high-
risk for OSA, sleep clinic availability is limited, costs are 
high, and the process itself is time-consuming. Therefore, 
portable monitors (PM’s), also known as limited channel 
testing (e.g. pulse oximetry alone or in conjunction with 
one to several other channels), have been proposed as an 
alternative method of OSA diagnosis in North America. 
While a full discussion of in-lab PSG versus PM testing 
is beyond the scope of the present article, this subject has 
recently been reviewed in depth in the context of testing 
commercial drivers for OSA
28). Generally, the best use of 
PM’s in North America is for confirming the presence of 
OSA in a patient seeking diagnosis who has already been 
deemed at high-risk based on symptoms and or screening. 
When OSA is confirmed in such a case with high pre-test 
probability, treatment can be recommended and imple-
mented without further testing. On the other hand, a nega-
tive or indeterminate result from a PM is not considered 
sufficient to exclude OSA in such a high-risk person
28).
The major concern in North America regarding the use 
of PM’s is the unique behavior of commercial drivers. 
Unlike the typical patient at a sleep clinic who is actively 
seeking diagnosis and treatment for a presumed sleep 
disorder, as discussed above in the section on screening, 
American commercial motor vehicle drivers actively avoid 
an OSA diagnosis because of its economic and occupa-
tional implications. Therefore, among commercial drivers 
motivated to gain/maintain employment, human factors 
that may alter test accuracy are a major potential obstacle 
to using PM’s in this population. We are aware of several 
scenarios whereby drivers could sabotage PM’s. They may 
attempt to stay awake all night to avoid sleep-disordered 
breathing events when the PM does not measure or esti-
mate sleep stages. In a second scenario for data fudging, 
drivers may place the device on a healthier family member 
to avoid an accurate diagnosis. For this reason, the most 
experts advocate using PM devices with “chain of cus-
tody” (a bracelet or other identifier placed on the driver by 
a professional technician), which deactivates the PM if the 
subject removes it
28).
Other potential issues with PM programs being mar-
keted to US trucking firms include testing and results 
interpretation protocols that may have no sleep specialist 
oversight, and sometimes minimal physician involvement. 
In addition, most PM’s cannot determine the total sleep 
time and therefore, cannot calculate a true AHI
28). Ad-
ditional studies comparing unattended and unmonitored 
PMs directly against full in-laboratory PSG are needed to 
provide evidence for their efficacy among American com-SLEEP APNEA IN COMMERCIAL DRIVERS 21
mercial motor vehicle operators.
Management and risk reduction of OSA among commercial 
drivers
Once diagnosed, Continuous Positive Airway Pressure 
(CPAP) is the first-line and best treatment for OSA among 
commercial drivers. Although other treatments are avail-
able, CPAP is the only non-operative therapy for which 
compliance can be objectively monitored
13, 14). Additional 
risk reduction methods include fitness and wellness 
programs, education and administrative controls, pre-
employment and regular OSA driver screening, and driver 
monitoring systems. Some of these measures have been 
recently reviewed
1).
Continuous positive airway pressure (CPAP)
Although published data are largely limited to non-com-
mercial drivers, evidence supports that CPAP treatment of 
OSA reduces motor vehicle accident risk. Several investi-
gations have reported reductions in crash risk
47, 65). Those 
OSA patients who were compliant with CPAP had fewer 
crashes, while OSA patients who did not use CPAP saw no 
change in crash rate
47). George and colleagues also found 
that CPAP treatment improved driver performance in those 
with previously untreated OSA and reduced the crash risk 
to levels comparable to that of the control group
66).
Although much of the literature indicates a positive re-
sult of CPAP therapy for individuals diagnosed with OSA, 
some literature suggests that residual consequences of 
OSA may persist even with CPAP treatment. Using driving 
simulator data, Vakulin et al. found that even after indi-
viduals with severe OSA followed their CPAP prescription 
closely for three months, their driving performance was 
still worse than the healthy control group
67). The authors 
suggested that neurobehavioral deficits may cause some 
long-term driving impairment in individuals with severe 
OSA despite a high adherence to CPAP treatment.
Shift work
Factors that heighten the risk of a driver becoming 
involved in an accident are not limited to sleep disorders. 
Fatigue is also related to the number of hours a driver has 
slept or rested, the time of day, whether they have taken 
drugs or medication, whether they have been drinking 
alcohol, and how long they have been driving without a 
break. Shift work is associated with disruption of circadian 
rhythms, a lower likelihood of getting adequate sleep and 
other factors that may increase fatigue at work
68). In addi-
tion, research has documented that the highest number and 
relative risks of motor vehicle accidents occur between 
the hours of midnight and six am
36). Moreover, shift work 
is likely to produce synergistic impairment with OSA. 
Therefore, we do not recommend rotating shifts or night 
shift driving for professional drivers with OSA even when 
they are compliant with CPAP treatment.
Fitness and wellness programs
Because obesity is a primary risk factor for OSA, an in-
vestment in employee fitness and wellness programs could 
have a potential return for the transportation industry. Such 
programs exist within the realm of productivity and health 
management, where employee health and employer costs 
are viewed from a holistic perspective with the ultimate 
goal of reducing costs and improving health.
Cost benefit
Limited data from the economic perspective support 
that industry-based programs to screen and diagnose OSA 
among drivers could save money. A cost-benefit analysis 
of OSA screening based on estimated vehicle crash costs 
concluded that commercial driver OSA screening should 
be cost-effective within the transportation industry
69). An-
other study of professional drivers supports cost-benefits 
based on medical costs
70). OSA is associated with higher 
risks of hypertension, incident diabetes mellitus, and 
incident cardiovascular events; therefore, we would expect 
that CPAP treatment ultimately decreases co-morbid medi-
cal costs.
Conclusion
Untreated OSA is associated with an increased risk of 
motor vehicle accidents. OSA is common among North 
American commercial drivers, underdiagnosed, and un-
dertreated. A number of effective screening strategies are 
available. Moreover, data support that treatment of OSA 
reduces the risk of motor vehicle accidents. Therefore, 
identifying commercial drivers with OSA and having them 
effectively treated should decrease crash-related fatalities 
and injuries.
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